Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolescents, and Young Adults

NCT00876031 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00876031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase-III Trial of the Cooperative Weichteilsarkom Study Group (CWS) for Localised High-risk Rhabdomyosarcoma and Localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in Children, Adolescents, and Young Adults
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2009
Completion date
June 30, 2022
Enrollment
195 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma